Trump FDA nominee Heidi Overton struggling to win GOP support
Summary
President Donald Trump's nominee for FDA commissioner, Dr. Heidi Overton, faces uncertain Republican support on the Senate health committee ahead of a Wednesday vote. The White House has discussed possible alternatives, including candidates who could serve as acting commissioner without Senate confirmation.Key Facts
- Republicans on the Senate Health, Education, Labor and Pensions Committee have not secured enough support to advance Overton's nomination, while committee Democrats are not expected to support it.
- The White House has begun speaking with potential replacement candidates, including people who could serve in an acting role.
- Overton faced questions about the abortion drug mifepristone and the administration's vaping policies during her nomination process.
- Sen. Josh Hawley has pressed for a promised safety study of mifepristone, while Sens. Susan Collins and Lisa Murkowski have not said how they will vote.
- The anti-abortion group Susan B. Anthony urged the Senate to delay the nomination and asked the FDA to restrict mail orders of mifepristone.
- Sources said Sen. Roger Marshall is seeking the FDA commissioner role; he lost his reelection bid to Democrat Adam Hamilton earlier this month.
- Acting Commissioner Kyle Diamantas currently leads the FDA. The agency oversees products that account for about 20% of consumer spending.
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.